期刊
MOLECULAR NEUROBIOLOGY
卷 51, 期 2, 页码 753-765出版社
SPRINGER
DOI: 10.1007/s12035-014-8723-8
关键词
Alzheimer's disease; CR1; Genetics; Pathogenesis
资金
- National Natural Science Foundation of China [81171209, 81371406, 81000544]
- Shandong Provincial Natural Science Foundation [ZR2011HZ001, ZR2010HQ004]
- Medicine and Health Science Technology Development Project of Shandong Province [2011WSA02018, 2011WSA02020]
- Innovation Project for Postgraduates of Jiangsu Province [CXLX13_561]
The complement component receptor 1 gene (CR1), which encodes a type-I transmembrane glycoprotein, has recently been identified as one of the most important risk genes for late-onset Alzheimer's disease (LOAD). In this article, we reviewed the recent evidence concerning the role of CR1 in LOAD. First, we introduced the structure, localization and physiological function of CR1 in humans. Afterward, we summarized the relation of CR1 polymorphisms with LOAD risk. Finally, we discussed the possible impact of CR1 on the pathogenesis of AD including amyloid-beta pathology, tauopathy, immune dysfunction and glial-mediated neuroinflammation. We hope that a more comprehensive understanding of the role that CR1 played in AD may lead to the development of novel therapeutics for the prevention and treatment of AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据